Brief: Alzinova Submits IND Application To FDA For Phase II Study

Alzinova AB

11/08/2025 06:31

Aug 11 (Reuters) - Alzinova AB ALZ.ST:

SUBMITS IND APPLICATION TO FDA FOR PHASE II STUDY

APPLIES FOR FAST TRACK DESIGNATION TO FDA

Source text: ID:nMFN4g5hKR

Further company coverage: ALZ.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))